Freshford Capital Management’s Zimmer Biomet ZBH Stock Holding History

Freshford Capital Management’s Portfolio ZBH Stock Details ZBH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-163,487	Closed	-$20.2M	–	27
2021 Q4	$20.2M	Sell	163,487 -55,961	-26%	-$7.32M	2.77%	15
2021 Q3	$31.2M	Buy	219,448 +45,894	+26%	+$6.75M	4.44%	11
2021 Q2	$27.1M	Sell	173,554 -9,614	-5%	-$1.56M	3.68%	12
2021 Q1	$28.5M	Sell	183,168 -2,666	-1%	-$413K	3.96%	10
2020 Q4	$27.8M	Sell	185,834 -4,476	-2%	-$632K	4.04%	10
2020 Q3	$25.2M	Buy	190,310 +18,398	+11%	+$2.4M	4.35%	8
2020 Q2	$19.9M	Sell	171,912 -15,949	-8%	-$1.84M	3.63%	9
2020 Q1	$18.4M	Sell	187,861 -76,344	-29%	-$10M	4.64%	9
2019 Q4	$38.4M	Sell	264,205 -1,073	-0.4%	-$148K	6.78%	6
2019 Q3	$35.4M	Buy	265,278 +58,255	+28%	+$7.53M	6.46%	6
2019 Q2	$23.7M	Buy	207,023 +86,513	+72%	+$10.1M	3.98%	11
2019 Q1	$14.9M	Buy	+120,510	New	+$13.7M	2.86%	14

Other funds holding ZBH

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Freshford Capital Management's ZBH Position: Q1 2022 in Review

Freshford Capital Management sold out of Zimmer Biomet (ZBH) in Q1 2022, closing a stake of 163,487 shares — an estimated $20.2M sold.

Freshford Capital Management first reported a position in ZBH in Q1 2019 and held it in 12 quarters. The position peaked at $38.4M in Q4 2019. 978 funds tracked by Wall St. Rank hold ZBH as of Q1 2022.

Freshford Capital Management reported no remaining Zimmer Biomet position as of Q1 2022 after selling out during the quarter.
Freshford Capital Management sold 163,487 Zimmer Biomet shares in Q1 2022, an estimated $20.2M.
Freshford Capital Management first reported a position in Zimmer Biomet in Q1 2019 and held it in 12 quarters.
Freshford Capital Management's Zimmer Biomet position peaked at $38.4M in Q4 2019.
978 funds tracked by Wall St. Rank held Zimmer Biomet as of Q1 2022.

Based on Freshford Capital Management's 13F filing for Q1 2022, filed 16 May 2022.